Citius Pharmaceuticals Inc (NASDAQ:CTXR)
| 1.22 Delayed Data As of Jun 09 |  -0.03 / -2.40%Today’s Change | 0.77 Today|||52-Week Range 1.71 | +54.43% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Depreciation And Amortization | -- | 1.3K | 2.6K | 1.8K | ||
| Operating Expenses | Gross Income | 0.00 | -1.3K | -2.6K | -1.8K | |
| General Expenses | 3.2M | 7.4M | 10.0M | 13.4M | ||
| Research And Development | 1.8M | 2.9M | 2.9M | 6.6M | ||
| Total Operating Expenses | 3.2M | 7.4M | 10.0M | 13.4M | ||
| Non-Operating Expenses | Operating Income | -3.2M | -7.4M | -10.0M | -13.4M | |
| Extraordinary Credit | 332.1K | 0.00 | 452.1K | 450.0K | ||
| Extraordinary Charge | 0.00 | -838.2K | 0.00 | -357.4K | ||
| Interest Expense On Debt | 7.5K | 9.0K | 850.8K | 15.8K | ||
| Other Expenses | 0.00 | 0.00 | 0.00 | 818.3K | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -2.9M | -8.3M | -10.4M | -12.5M | |
| Net Income | -2.9M | -8.3M | -10.4M | -12.5M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 2.1M | 3.6M | 5.5M | 10.7M | |
| Shares To Calculate EPS Diluted | 2.1M | 3.6M | 5.5M | 10.7M | ||
| Earnings Per Share | EPS | -$1.35 | -$2.25 | -$1.89 | -$1.17 | |
| EPS Diluted | -$1.35 | -$2.25 | -$1.89 | -$1.17 | ||
